JP2023543029A5 - - Google Patents
Info
- Publication number
- JP2023543029A5 JP2023543029A5 JP2023519230A JP2023519230A JP2023543029A5 JP 2023543029 A5 JP2023543029 A5 JP 2023543029A5 JP 2023519230 A JP2023519230 A JP 2023519230A JP 2023519230 A JP2023519230 A JP 2023519230A JP 2023543029 A5 JP2023543029 A5 JP 2023543029A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- approximately
- use according
- raav
- item
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063084259P | 2020-09-28 | 2020-09-28 | |
| US63/084,259 | 2020-09-28 | ||
| PCT/US2021/052425 WO2022067257A1 (en) | 2020-09-28 | 2021-09-28 | Products and methods for treating muscular dystrophy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543029A JP2023543029A (ja) | 2023-10-12 |
| JP2023543029A5 true JP2023543029A5 (https=) | 2024-10-07 |
Family
ID=80846947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023519230A Pending JP2023543029A (ja) | 2020-09-28 | 2021-09-28 | 筋ジストロフィーの治療のための製品及び方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240261434A1 (https=) |
| EP (1) | EP4217375A1 (https=) |
| JP (1) | JP2023543029A (https=) |
| AU (1) | AU2021349277A1 (https=) |
| CA (1) | CA3194122A1 (https=) |
| WO (1) | WO2022067257A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2023228712A1 (en) | 2022-03-04 | 2024-10-17 | Regeneron Pharmaceuticals, Inc. | Compositions and methods comprising engineered small nuclear rna (snrna) |
| WO2025072530A2 (en) * | 2023-09-26 | 2025-04-03 | Regeneron Pharmaceuticals, Inc. | Compositions and methods comprising small nuclear rna (snrna) for treating dmd |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5173414A (en) | 1990-10-30 | 1992-12-22 | Applied Immune Sciences, Inc. | Production of recombinant adeno-associated virus vectors |
| PT728214E (pt) | 1993-11-09 | 2004-11-30 | Ohio Med College | Linhas celulares estaveis capazes de expressar o gene de replicacao do virus adeno-associado |
| WO1995013365A1 (en) | 1993-11-09 | 1995-05-18 | Targeted Genetics Corporation | Generation of high titers of recombinant aav vectors |
| US5658785A (en) | 1994-06-06 | 1997-08-19 | Children's Hospital, Inc. | Adeno-associated virus materials and methods |
| US5856152A (en) | 1994-10-28 | 1999-01-05 | The Trustees Of The University Of Pennsylvania | Hybrid adenovirus-AAV vector and methods of use therefor |
| CA2207927A1 (en) | 1994-12-06 | 1996-06-13 | Targeted Genetics Corporation | Packaging cell lines for generation of high titers of recombinant aav vectors |
| FR2737730B1 (fr) | 1995-08-10 | 1997-09-05 | Pasteur Merieux Serums Vacc | Procede de purification de virus par chromatographie |
| WO1997008298A1 (en) | 1995-08-30 | 1997-03-06 | Genzyme Corporation | Chromatographic purification of adenovirus and aav |
| US6632670B1 (en) | 1995-09-08 | 2003-10-14 | Genzyme Corporation | AAV vectors for gene therapy |
| US5910434A (en) | 1995-12-15 | 1999-06-08 | Systemix, Inc. | Method for obtaining retroviral packaging cell lines producing high transducing efficiency retroviral supernatant |
| JP2001500497A (ja) | 1996-09-06 | 2001-01-16 | トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 組換えアデノ随伴ウイルスに指図される遺伝子治療の方法 |
| DK1009808T3 (da) | 1997-09-05 | 2013-01-21 | Genzyme Corp | Fremgangsmåder til generering af hjælper-frie præparater af rekombinante aav-vektorer med høj titer |
| US6566118B1 (en) | 1997-09-05 | 2003-05-20 | Targeted Genetics Corporation | Methods for generating high titer helper-free preparations of released recombinant AAV vectors |
| US6258595B1 (en) | 1999-03-18 | 2001-07-10 | The Trustees Of The University Of Pennsylvania | Compositions and methods for helper-free production of recombinant adeno-associated viruses |
| US7056502B2 (en) | 2000-04-28 | 2006-06-06 | The Trustees Of The University Of Pennsylvania | Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids |
| WO2002053703A2 (en) | 2001-01-05 | 2002-07-11 | Children's Hospital, Inc. | Aav2 vectors and methods |
| PT1453547T (pt) | 2001-12-17 | 2016-12-28 | Univ Pennsylvania | Sequências do vírus adeno-associado (aav) do serotipo 8, vetores contendo as mesmas, e utilizações destas |
| DE102012007232B4 (de) | 2012-04-07 | 2014-03-13 | Susanne Weller | Verfahren zur Herstellung von rotierenden elektrischen Maschinen |
| MX388221B (es) * | 2013-04-20 | 2025-03-19 | Res Institute At Nationwide Children´S Hospital | ADMINISTRACIÓN DE VIRUS ADENO-ASOCIADO RECOMBINANTE DE CONSTRUCCIONES DE POLINUCLÉOTIDOS U7snRNA DIRIGIDA AL EXÓN 2. |
| JP2015092462A (ja) | 2013-09-30 | 2015-05-14 | Tdk株式会社 | 正極及びそれを用いたリチウムイオン二次電池 |
| WO2015141521A1 (ja) | 2014-03-21 | 2015-09-24 | 株式会社日立国際電気 | 基板処理装置、半導体装置の製造方法及び記録媒体 |
| CA2957661A1 (en) * | 2014-08-09 | 2016-02-18 | Kevin FLANIGAN | Methods and materials for activating an internal ribosome entry site in exon 5 of the dmd gene |
| JP6197169B2 (ja) | 2014-09-29 | 2017-09-20 | 東芝メモリ株式会社 | 半導体装置の製造方法 |
-
2021
- 2021-09-28 AU AU2021349277A patent/AU2021349277A1/en active Pending
- 2021-09-28 CA CA3194122A patent/CA3194122A1/en active Pending
- 2021-09-28 EP EP21806444.2A patent/EP4217375A1/en active Pending
- 2021-09-28 US US18/246,594 patent/US20240261434A1/en active Pending
- 2021-09-28 WO PCT/US2021/052425 patent/WO2022067257A1/en not_active Ceased
- 2021-09-28 JP JP2023519230A patent/JP2023543029A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527657A5 (https=) | ||
| JP2024515720A5 (https=) | ||
| JP2022544627A5 (https=) | ||
| JP2023543029A5 (https=) | ||
| JP7399507B2 (ja) | 乾癬を治療又は予防する薬物の製造におけるアネモシドｂ４の用途 | |
| JP2018527365A5 (https=) | ||
| JP2018510219A5 (https=) | ||
| JP2009521398A5 (https=) | ||
| JP2022521776A5 (https=) | ||
| JP2016538885A5 (https=) | ||
| AU2024278563A1 (en) | Means and methods for AAV gene therapy in humans | |
| Chen et al. | A single dose of Anti-HBsAg antibody-encoding mRNA-LNPs suppressed HBsAg expression: a potential cure of chronic hepatitis B virus infection | |
| Pan et al. | Ginkgo biloba extract EGb761 attenuates bleomycin-induced experimental pulmonary fibrosis in mice by regulating the balance of M1/M2 macrophages and nuclear factor kappa B (NF-κB)-mediated cellular apoptosis | |
| JP2024527742A5 (https=) | ||
| Porter et al. | A single surface-exposed amino acid determines differential neutralization of AAV1 and AAV6 by human alpha-defensins | |
| Gerner et al. | Vitamin E treatment for children with chronic hepatitis B: a randomized placebo controlled trial | |
| PT1624076E (pt) | Detecção quantitativa do hdv por pcr à ta em tempo real | |
| CN117017996B (zh) | Navitoclax（ABT263）在制备广谱抗病毒抑制剂中的应用 | |
| CN107617101B (zh) | 含唑来膦酸和白细胞介素2的药物组合及其应用 | |
| CN115837026B (zh) | 一种组合物及其在制备具有抗肝炎作用的药物中的应用 | |
| CA3005313C (en) | Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide) | |
| Gul et al. | Anti-MDA5 antibody-positive dermatomyositis with severe cutaneous ulcers | |
| Paximadis et al. | Hepatitis B and HIV-1 2019 IAS Cure Forum: lessons and benefits from interdisciplinary research | |
| US20240316027A1 (en) | Use of maraviroc in preparation of drugs for treatment of muscle degenerative diseases | |
| Kaiser et al. | Successful retreatment of peginterferon nonresponder patients with chronic hepatitis C with high dose consensus interferon induction therapy |